Every Form 4 that COMPASS Pathways Plc (CMPS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CMPS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMPS filings page.
COMPASS Pathways plc Chief Executive Officer Kabir Nath reported an insider transaction involving 5,962 Ordinary Shares on August 3, 2026. These shares were withheld by the issuer at $11.25 per share to satisfy tax withholding obligations upon vesting of restricted share units, rather than sold in the open market. After this tax-withholding disposition, Nath directly holds 361,028 Ordinary Shares, which may be represented by an equal number of American Depositary Shares.
COMPASS Pathways plc director Daphne Karydas received a grant of share options covering 21,110 ordinary shares. These options have an exercise price of $11.85 per share and were awarded at no cost as a compensation grant.
The options vest in full on the earlier of the first anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders, and they expire in 2036. Each ordinary share may be represented by one American Depositary Share.
COMPASS Pathways plc director Gino Santini received a grant of share options covering 30,158 Ordinary Shares. These options have an exercise price of $11.85 per share and expire on May 26, 2036. The options vest in full on the earlier of the first anniversary of the grant date or the company’s Annual General Meeting of Shareholders in 2027. Following this compensation award, Santini holds options for 30,158 shares, which may be exercised into Ordinary Shares that can be represented by American Depositary Shares on a one-for-one basis.
COMPASS Pathways plc director Justin D. Gover received a grant of share options over 21,110 Ordinary Shares. These options have an exercise price of $11.85 per share and expire on May 26, 2036. The shares underlying this option vest in full on the earlier of the first anniversary of the grant date or the company’s Annual General Meeting of Shareholders in 2027. The options are held directly and may be exercised for Ordinary Shares, which may be represented by American Depositary Shares, each currently equal to one Ordinary Share.
COMPASS Pathways plc director Jeffrey M. Jonas received a grant of share options linked to 21,110 Ordinary Shares. The options carry an exercise price of $11.85 per share and expire in 2036. They vest in full on the earlier of one year from grant or the company’s 2027 annual shareholder meeting.
COMPASS Pathways plc director Wayne Joseph Riley received a grant of share options covering 21,110 Ordinary Shares. These options were awarded at an exercise price of $11.85 per share and are held directly. Following the grant, his option holdings reported in this filing total 21,110 shares.
The option vests in full on the earlier of the first anniversary of the grant date or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027, and expires on May 26, 2036. The Ordinary Shares may be represented by American Depositary Shares, each currently representing one Ordinary Share.
COMPASS Pathways plc director Robert McQuade received a grant of share options covering 21,110 Ordinary Shares. These options have an exercise price of $11.85 per share and expire on May 26, 2036. Following this award, he holds options for 21,110 shares directly.
The options vest in full on the earlier of the first anniversary of the grant date or the company’s Annual General Meeting of Shareholders in 2027. The underlying Ordinary Shares may be represented by American Depositary Shares, with each ADS currently representing one Ordinary Share.
COMPASS Pathways plc director David Y. Norton received a grant of share options giving him the right to buy 21,110 Ordinary Shares. The options have an exercise price of $11.85 per share and expire on 26 May 2036. The underlying shares vest in full on the earlier of the first anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders. The Ordinary Shares may be represented by American Depositary Shares on a 1:1 basis.
COMPASS Pathways plc director Kathleen Tregoning received a grant of share options covering 41,119 Ordinary Shares. The options have an exercise price of 11.85 per share and expire on May 26, 2036.
The award vests in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on June 27, 2026. The Ordinary Shares may be represented by American Depositary Shares, each currently representing one Ordinary Share.
COMPASS Pathways plc reported that Chief Executive Officer Kabir Nath received new equity-based compensation. He was granted options to purchase 367,815 Ordinary Shares at an exercise price of $5.64 per share, vesting in forty-eight equal monthly installments beginning on April 26, 2026.
He was also granted 175,000 Ordinary Shares in the form of Restricted Share Units under the 2020 Share Option and Incentive Plan. These RSUs vest in four equal annual installments, with the first installment vesting on March 26, 2027. Following the RSU grant, he directly holds 366,990 Ordinary Shares.
Compass Pathways plc reported that Chief Medical Officer Guy Goodwin received two new stock option awards. He was granted options over 55,000 ordinary shares at an exercise price of 0.01 per share and options over 115,600 ordinary shares at an exercise price of 5.64 per share.
The 55,000-share nominal cost option vests in four equal annual installments beginning on March 26, 2027. The 115,600-share option vests in 48 equal monthly installments beginning on April 26, 2026. Each ordinary share may be represented by one American Depositary Share. No open-market purchases or sales were reported in this filing.
Compass Pathways plc Chief Financial Officer Teri Loxam received new equity awards as part of compensation. She was granted share options covering 157,635 Ordinary Shares at an exercise price of $5.64 per share, expiring on March 25, 2036. These options vest in forty-eight equal monthly installments beginning on April 26, 2026.
She also received 75,000 Restricted Share Units (RSUs), each representing one Ordinary Share, with vesting in four equal annual installments starting on March 26, 2027. Following this RSU grant, she directly owns 152,002 Ordinary Shares. The company notes that Ordinary Shares may be represented by American Depositary Shares, each currently representing one Ordinary Share.
COMPASS Pathways plc reported a routine insider tax-related transaction by its Chief Executive Officer, Kabir Nath. On March 11, 2026, 13,131 Ordinary Shares were disposed of at $6.89 per share, but this was a tax-withholding disposition rather than an open-market sale. The shares were withheld by the company upon the vesting of restricted share units to cover tax obligations, so the CEO did not actively trade these shares in the market. Following this event, Nath directly owned 191,990 Ordinary Shares. Each Ordinary Share may be represented by an American Depositary Share on the U.S. market.
COMPASS Pathways plc Chief Financial Officer Teri Loxam reported a routine tax-related share disposition. On the vesting of restricted share units, 1,781 Ordinary Shares were withheld by the company at a value of $6.89 per share to satisfy tax withholding obligations. After this withholding, Loxam directly owns 77,002 Ordinary Shares, which may be represented by American Depositary Shares on a one-for-one basis.
COMPASS Pathways plc Chief Financial Officer Teri Loxam reported a tax-related share disposition. On the transaction date, 4,467 Ordinary Shares were withheld by the company upon vesting of restricted share units to satisfy tax withholding obligations. After this withholding, Loxam directly owned 78,783 Ordinary Shares.
COMPASS Pathways plc reported an insider equity transaction by Chief Executive Officer and director Kabir Nath. On 02/02/2026, 16,181 Ordinary Shares were withheld by the company at $6.61 per share to cover tax obligations arising from vested restricted share units.
Following this non‑open‑market, tax‑withholding transaction, Nath directly beneficially owned 205,121 Ordinary Shares. The filing notes that the company’s Ordinary Shares may also trade as American Depositary Shares, with each ADS currently representing one Ordinary Share.
COMPASS Pathways plc director Jeffrey M. Jonas reported an option grant to acquire 52,000 Ordinary Shares at an exercise price of $6.33 on October 29, 2025. The option vests in 36 equal monthly installments over three years, with the first tranche vesting on November 29, 2025, and expires on October 28, 2035. The options are held directly. Each American Depositary Share currently represents one Ordinary Share.